Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2023-02-10 00:00:00 ET · period of report 2023-02-09 · accession 0001567619-23-002403 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | 2023-02-09 | PCSA | Stanker James H | CFO | A - Grant | $0.8 | +12.5K | 61.8K | +25% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | A | A | 12,500 | $0.8 | 61,750 | D | — | — |